Gene Expression-Based Predictive Markers for Paclitaxel Treatment in ER+ and ER− Breast Cancer

One of the objectives of precision oncology is to identify patient’s responsiveness to a given treatment and prevent potential overtreatments through molecular profiling. Predictive gene expression biomarkers are a promising and practical means to this purpose. The overall response rate of paclitaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaowen, Wang, Edwin, Cui, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405635/
https://www.ncbi.nlm.nih.gov/pubmed/30881385
http://dx.doi.org/10.3389/fgene.2019.00156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405635/
https://www.ncbi.nlm.nih.gov/pubmed/30881385
http://dx.doi.org/10.3389/fgene.2019.00156

Ejemplares similares